Health
PharmAust (ASX:PAA) advances testing against COVID-19 – The Market Herald
Clinical-stage oncology PharmAust (ASX:PAA) has advanced its monepantel drugs testing against COVID-19, in the race to find a vaccine for the virus
- Clinical-stage oncology PharmAust (PAA) has signed an agreement with Leiden University Medical (LUMC) for its monepantel drugs testing against COVID-19
- LUMC will test the effects of monepantel and monepantel sulfone on the replication of SARS-CoV-2 in cell lines
- Under the agreement, PharmAust will pay a fee to LUMC and will own all intellectual property results generated from the study
- The study will be overseen by Dr Martijn van Hemert, Principal Investigator of …
Continue Reading
-
Noosa News16 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News21 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News14 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News23 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common